Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer by Swain S M, Whaley F S, Gerber M C, Weisberg S, York M, Spicer D, Jones S E, Wadler S, Desai A, Vogel C, Speyer J, Mittelman A, Reddy S, Pendergrass K, Velez-Garcia E, Ewer M S, Bianchine J R, Gams R A in Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1997).

[PMID: 9193323] PubMed


To determine the cardioprotective effect of dexrazoxane (DZR) used in a doxorubicin-based combination therapy in advanced breast cancer.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.